Opportunities
Accelerating Medical Device and Diagnostic Reimbursement—Network Survey
As a funder of technology innovation in a vibrant health ecosystem, the Advanced Research Projects Agency for Health (ARPA-H) seeks to provide best-in-class and novel services and partnerships to help accelerate the reimbursement process for innovative medical devices and diagnostics following their authorization from the U.S. Food and Drug Administration (FDA).
To support this effort, the Investor Catalyst Hub issued a network survey to collect expert input from medical technology developers and manufacturers, payors, healthcare providers, and other key stakeholders uniquely positioned to provide valuable insights about the reimbursement process. These inputs will help inform ARPA-H on how to close the median reimbursement approval gap for relevant agency-funded efforts from 5.7 years to 2 years.
Medical Imaging Data Marketplace—Network Survey
ARPA-H and the Center for Devices and Radiological Health of the FDA are partnering to streamline access to affordable, high-quality, regulatory-ready medical imaging data. The agencies are exploring the development of a medical imaging data marketplace to expedite innovation in Software as a Medical Device (SaMD) and other artificial intelligence and machine learning-enabled medical devices.
In support of this initiative, the Investor Catalyst Hub issued a network survey to collect feedback about specific needs and challenges that medical imaging software and product developers; users of artificial intelligence and machine learning medical imaging products; and private and public organizations face with utilizing, managing, and producing data for product development and evaluation. Equipped with the survey findings, ARPA-H launched the ImagiNg Data EXchange (INDEX) program, which aims to revolutionize medical artificial intelligence AI tool development.
Sprint for Women’s Health
ARPA-H and the Investor Catalyst Hub launched the Sprint for Women’s Health with $113M committed to fund bold and transformative women’s health solutions. Twenty-three performers have been selected, spanning six health areas. The Sprint for Women’s Health received over 1,700 submissions representing 45 states, the District of Columbia, and 34 countries. Of the 24 awardees, 30% have never received government funding and over 70% are led by women. The awardees will work directly with an ARPA-H Program Manager and the Investor Catalyst Hub to develop their proposed solution over two years.
HEROES
The ARPA-H HEalthcare Rewards to Achieve Improved OutcomES (HEROES) program aims to trial and validate a unified approach to creating preventative care incentives in the health market. This approach involves offering funding to health accelerators that implement preventative care campaigns. The Investor Catalyst Hub’s network helped ARPA-H create coalitions of healthcare providers, technologists, and impact investors working together to achieve results-driven health outcomes across entire communities. Our ecosystem hosted events and offered technical assistance across cardiovascular health, maternal health, and opioid overdose prevention.